logo
Workers' stress complaints drive surge in private mental health clinics

Workers' stress complaints drive surge in private mental health clinics

Yahoo24-04-2025
Workers complaining of stress are fuelling a boom in private mental health clinics.
Bupa is to launch mental health centres across the UK to deal with an 'exponential' rise in demand from stressed workers.
Its 70 'mindspace' centres will focus on corporate clients and their family members.
Bupa's chief executive said businesses were crying out for more help, with sick leave rising and productivity falling. The company has seen demand for access to mental health treatments rise by 20 per cent year on year since 2020.
The initiative comes as Wes Streeting launches a call for evidence, inviting individuals and organisations to offer expertise informing decision-making, ahead of the first-ever men's health strategy.
The Health Secretary said men were being 'hit harder' by health problems, with suicide the leading cause of death for men under 50.
Across the country, mental health claims have fuelled a surge in benefits payments post-Covid, while overall spending on working age sickness and disability benefits have risen by £20 billion.
One in four pounds paid in income tax is expected to go towards sickness benefits by the end of this decade, unless the trajectory changes.
On Thursday, Bupa's chief executive announced plans to launch 20 'mindspace' centres this year, starting in Guildford, Reading and Bristol – the areas identified as having the highest demand. In total, 70 such facilities will be opened by the end of 2027.
Carlos Jaureguizar, the chief executive of Bupa Global, India & UK, said mental health was now one of the biggest challenges facing businesses, with the new centres aimed at providing help quickly, before individuals reach crisis point.
He said: 'Since 2020, demand for mental health services has grown exponentially for the workforce and their wider family unit, particularly young people. There is an increasing need for mental health support across the UK and fast access to services has never been more important.'
'When we talk to our big corporate clients and our SMEs [small to medium sized enterprises], this trend is really impacting their employees, their capacity to work, their sick leave and the productivity of the country, so we need to do something to solve that.'
He said the centres would ensure clients received fast access to face-to-face care, with a focus on prevention.
The service will be offered to individual customers, as well as corporate clients, and later be made available for self-pay customers.
Mr Jaureguizar said: 'Mindspace facilities will help people get fast access to face-to-face care. They reflect our commitment to prevention, identifying urgent needs amongst our customers where early intervention can lead to better health outcomes.'
Last month, a report by PwC suggested that Generation Z were giving up on work, with almost four in 10 considering leaving their job and ending up on benefits.
It warned that a generation of workers was now in danger of permanently drifting out of the jobs market and identified mental health conditions as a 'major driver' of youth worklessness.
PwC said economic inactivity, where people are neither in work nor looking for a job, was on course to rise further, with 4.4 million workers – one in 10 of the overall workforce – now 'on the brink of leaving the labour market'.
In a stark warning, the Big Four accountancy firm, which employs roughly 26,000 people in the UK, also said many employers were wary of taking on people who had been out of work for an extended period.
Research by benefits provider Unum suggests that one in three UK employees experience some form of mental health concern annually, with a quarter saying their mental wellbeing has worsened in the past year.
Meanwhile, analysis by accounting firm Deloitte found that mental health problems are costing UK companies £51 billion each year.
It also noted that while cost of living, job security and personal or family finances were top priorities among working adults, children's mental health was one of the greatest concerns for almost half of working parents.
The centres will be accessible to Bupa's four million UK insurance customers, many of whom have corporate accounts.
The mindspace facilities will offer access to face-to-face talking therapies, including counselling, psychology, psychotherapy and cognitive behavioural therapy.
Mindspace facilities will become available to self-pay customers shortly after.
A survey this year found that one in three young workers have taken sick days because of mental health issues triggered by stress.
Some 35 per cent of employees aged 18 to 24 reported feeling so unwell as a result of stress that they had to take time off from work last year, according to charity Mental Health UK.
On Thursday, Mr Streeting will promise action to prevent and tackle the biggest health problems facing men, and to 'close the life-expectancy gap', which sees men die almost four years earlier than women on average.
'Every day, men across England are dying early from preventable causes. Men are hit harder by a range of conditions, while tragically suicide is the leading cause of death for men under 50.
'Our Plan For Change means we will tackle these issues head on through a men's health strategy, and today's call for evidence is the crucial next step in understanding what works, what doesn't, and how we can design services men will actually use,' he said, urging the public to share their views.
The call for evidence will be open for 12 weeks on the Department of Health and Social Care website.
Amy O'Connor, from the men's health charity Movember, said: 'Too many men are dying too young. The men's health strategy is a once-in-a-generation opportunity to invest in positive change for men and their loved ones.
Julie Bentley, the chief executive of Samaritans, said: 'Suicide is the biggest killer of men under 50 so it's critical that suicide prevention is front and centre of this strategy. With men making up 75 per cent of all suicides, this strategy is a real opportunity to prevent thousands of deaths.'
Earlier this year, Sir Keir Starmer, the Prime Minister, rejected the suggestion that a 'minister for men' was needed after calls were made for a government position specifically addressing issues such as behaviour, education and poor mental health.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr.

time3 hours ago

Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr.

The American Academy of Pediatrics (AAP) said on Tuesday that children ages 6 months to 23 months should receive a COVID-19 vaccine, in contrast with federal health officials. The recommendations are part of the AAP's annual childhood immunization schedule, which includes guidance for COVID, flu and RSV vaccines for those aged 18 and younger. The AAP has been releasing its own recommendations since the 1930s, but in a rare occurrence, the recommendations differ from those put out by the Centers for Disease Control and Prevention (CDC). The group also recommended Americans age 18 and under receive a COVID vaccine if they are at high risk of severe COVID, live in a long-term care facility or congregate setting, if they have never been vaccinated against COVID or if they live with someone at high risk for severe COVID. It comes after Health and Human Services secretary Robert F. Kennedy Jr. announced in late May that the CDC would no longer recommend the COVID vaccine for healthy children. The CDC, which is under Kennedy's purview, later updated the guidance to a " shared clinical decision making" model -- leaving the decision to vaccinate children to parents alongside advice from a doctor. The prior recommendations were that everyone aged 6 months and older get vaccinated against COVID with the most up-to-date shot. The contrasting vaccine recommendations highlight the growing rift between federal health officials and medical organizations on vaccine policy. "The academy has been making pediatric immunization recommendations since the 1930s, that has not changed," Dr. Susan J. Kressly, president of the AAP, told ABC News. "But what has changed is that this year, we're doing it in the environment of misinformation, which makes it more important than ever that we provide clear and confident guidance, because the majority of American families really depend on us for this guidance." Children between 6 months old and 23 months old are at the highest risk of severe COVID-19, and the vaccine can protect against serious illness, according to the AAP. "We know that this age group, that's the highest risk for severe disease," Kressly said. "And so we want to make sure that those children who are at highest risk and did not live through the pandemic -- they were not exposed to COVID viruses during the pandemic -- we want to make sure that they are protected as best as possible." Although medical organizations may differ in their vaccine recommendations, insurers often rely on the CDC's vaccine panel, known as the Advisory Committee on Immunization Practices (ACIP), recommendations to determine what they will and won't cover. If certain vaccines aren't recommended by the ACIP, it may lead to parents or guardians facing out-of-pocket costs if their children receive the shot. It could also mean the shots aren't covered by the Vaccines for Children (VFC) program, a federally funded program that provides no-cost vaccines to eligible children. "We need to work with our like-minded policy makers who understand the importance of keeping VFC vaccines available in every community for those children who depend on them," Kressly said. "At the same time, there are children in this country whose vaccines are paid for through commercial insurance, and we are having continuing conversations with major payers to make sure that those can be vaccines are available as well. Vaccination is part of high-quality preventive care, and we are confident that we can work with the payers to make sure that translated into policy."

Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine
Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

Business Insider

time4 hours ago

  • Business Insider

Pfizer Canada, BioNTech get Health Canada approval for COVID variant vaccine

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The updated COMIRNATY vaccine targets the Omicron LP.8.1 variant, one of the most recently circulating SARS-CoV-2 lineages. This season's Pfizer and BioNTech COVID-19 vaccine will be available in pharmacies across the country in the fall. The public program operates according to the eligibility criteria determined by each province. If an individual meets these criteria, they will be eligible to receive the vaccine for free. Efforts are ongoing in collaboration with private insurers and payers to streamline reimbursement processes within the private sector, for those who do not meet public program requirements. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Invivyd says PEMGARDA effective against XFG variant of SARS-CoV-2
Invivyd says PEMGARDA effective against XFG variant of SARS-CoV-2

Business Insider

time4 hours ago

  • Business Insider

Invivyd says PEMGARDA effective against XFG variant of SARS-CoV-2

Invivyd (IVVD) announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA against the currently dominant and growing XFG variant of SARS-CoV-2. Notably, and consistent with all dominant variants for the past three years, XFG did not generate any meaningful change to the in vitro neutralization activity of pemivibart or VYD2311, the company's next generation COVID-19 monoclonal antibody candidate, as the epitopes targeted by pemivibart and VYD2311 remain structurally intact. PEMGARDA is authorized by the U.S. FDA for pre-exposure prophylaxis of COVID-19 in certain immunocompromised patients. Currently, the level of COVID-19 viral activity detected in wastewater in 12 states is reported as high or very high levels as of early August, and the U.S. Centers for Disease Control and Prevention estimates that COVID-19 infections are growing or likely growing in 34 states and declining in zero states, according to forecasting models. Further, the company estimates that every clinical variant reported in the CDC COVID Data Tracker since the Omicron BA.2 lineage has been susceptible to pemivibart, even if untested, due to the consistent structural integrity of the epitope targeted by pemivibart. Therefore, Invivyd anticipates continued meaningful clinical activity for pemivibart for the foreseeable future if the epitope pemivibart targets remains intact. Elevate Your Investing Strategy:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store